We set out to identify microbial strains with GLP-1 stimulatory activity as potential metabolic disease therapeutics
The information contained in this content is not meant to diagnose, treat, cure, or prevent any disease
A major study, published in 2025, on the link between the intake of various food groups and risk of overweight and obesity found diets rich in whole grains, legumes, nuts, and fruit are linked with a lower risk of overweight and obesity (8)
Differences: Duration of Action: Short-acting GLP-1RAs (e.g., exenatide twice daily or lixisenatide) act by primarily delaying gastric emptying
Martha S, Pantam N, Thungathurthi S, Rao VLN, Devarakonda K